Your browser doesn't support javascript.
loading
Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population.
Rubio-Briones, Jose; Borque-Fernando, Angel; Esteban, Luis M; Mascarós, Juan M; Ramírez-Backhaus, Miguel; Casanova, Juan; Collado, Argimiro; Mir, Carmen; Gómez-Ferrer, Alvaro; Wong, Augusto; Aragón, Fuensanta; Calatrava, Ana; López-Guerrero, Jose A; Groskopf, Jack; Schalken, Jack; Van Criekinge, Wim; Domínguez-Escrig, Jose.
Afiliação
  • Rubio-Briones J; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Borque-Fernando A; Department of Urology, IIS-Aragón, University Hospital Miguel Servet, Zaragoza, Spain.
  • Esteban LM; Department of Applied Mathematics, Universitary Politecnic School of La Almunia, University of Zaragoza, Zaragoza, Spain.
  • Mascarós JM; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Ramírez-Backhaus M; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Casanova J; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Collado A; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Mir C; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Gómez-Ferrer A; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Wong A; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Aragón F; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Calatrava A; Department of Pathology, Instituto Valenciano de Oncología, Valencia, Spain.
  • López-Guerrero JA; Department of Urology, Molecular Biology Laboratory, Instituto Valenciano de Oncología, Valencia, Spain.
  • Groskopf J; Department of Research in Biomarkers, MDxHealth, Irvine, California.
  • Schalken J; Department of Experimental Urology, Radboud University, Nijmegen, The Netherlands.
  • Van Criekinge W; Department of Bioinformatics, Ghent University, Ghent, Belgium.
  • Domínguez-Escrig J; Department of Urology, Instituto Valenciano de Oncología, Valencia, Spain.
Prostate ; 80(6): 500-507, 2020 05.
Article em En | MEDLINE | ID: mdl-32077525
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / RNA Mensageiro Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / RNA Mensageiro Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos